AWP Class Action Proceeds; Congress’ Inaction Is No Defense, Judge Rules
Executive Summary
Pharmaceutical manufacturers cannot use the lack of Congressional action on AWP reform as a defense in class action suits filed over the issue, Boston federal court Judge Patti Saris ruled
You may also be interested in...
Together Rx Cited In AWP Price-Fixing Suit; Amended Complaint Drops Merck
A class action suit alleges manufacturers participating in the Together Rx discount drug card program are involved in a conspiracy to increase the average wholesale price "spread" on products in the program
Together Rx Cited In AWP Price-Fixing Suit; Amended Complaint Drops Merck
A class action suit alleges manufacturers participating in the Together Rx discount drug card program are involved in a conspiracy to increase the average wholesale price "spread" on products in the program
Medicare Rx Reimbursement Drops to AWP-15% Under Senate Tax Bill
The Senate tax bill would cut Medicare Part B reimbursement for drugs to 85% of AWP